Reshape Lifesciences Inc

NEW
NAS:RSLS (USA)  
$ 5.66 +0.2 (+3.67%) 07:08 PM EST
At Loss
P/B:
0.94
Volume:
57.79K
Avg Vol (2M):
284.99K
Trade In:
Volume:
57.79K
At Loss
Avg Vol (2M):
284.99K

Business Description

Reshape Lifesciences Inc
NAICS : 334510 SIC : 3845
ISIN : US76090R2004
Description
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
Name Current Vs Industry Vs History
Cash-To-Debt 4.88
Equity-to-Asset 0.48
Debt-to-Equity 0.07
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -142.35
Distress
Grey
Safe
Beneish M-Score -3.48
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 39.45
9-Day RSI 43.3
14-Day RSI 42.45
6-1 Month Momentum % -41.32
12-1 Month Momentum % -60.4

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.9
Quick Ratio 0.89
Cash Ratio 0.33
Days Inventory 472.14
Days Sales Outstanding 109.3
Days Payable 197.94

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 59.7
Shareholder Yield % -1.67

Financials (Next Earnings Date:2024-11-08 Est.)

RSLS's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RSLS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Reshape Lifesciences Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 8.046
EPS (TTM) ($) -72.058
Beta 1.57
Volatility % 83.77
14-Day RSI 42.45
14-Day ATR ($) 0.780734
20-Day SMA ($) 5.47466
12-1 Month Momentum % -60.4
52-Week Range ($) 4.6 - 34.22
Shares Outstanding (Mil) 0.51

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Reshape Lifesciences Inc Filings

Filing Date Document Date Form
No Filing Data

Reshape Lifesciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Reshape Lifesciences Inc Frequently Asked Questions

What is Reshape Lifesciences Inc(RSLS)'s stock price today?
The current price of RSLS is $5.66. The 52 week high of RSLS is $34.22 and 52 week low is $4.60.
When is next earnings date of Reshape Lifesciences Inc(RSLS)?
The next earnings date of Reshape Lifesciences Inc(RSLS) is 2024-11-08 Est..
Does Reshape Lifesciences Inc(RSLS) pay dividends? If so, how much?
Reshape Lifesciences Inc(RSLS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1